Gene · 10549
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated Peroxiredoxins in Bladder Cancer Are Associated With an Altered Tumour Immune Microenvironment. | J Cell Mol Med | 2026 | 41761027 | PubTator, text mining | PubMed |
| Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer. | Biomedicines | 2026 | 41751162 | PubTator, text mining | PubMed |
| Moonlighting Functions of Mammalian Peroxiredoxins in Cellular Signaling. | Antioxidants (Basel) | 2026 | 41750610 | PubTator, text mining | PubMed |
| Single-cell analysis reveals the cellular and transcriptional heterogeneity of the normal pediatric thyroid. | Front Endocrinol (Lausanne) | 2026 | 41727685 | PubTator, text mining | PubMed |
| Plasma Proteome Profiling of Centenarian Across Switzerland Reveals Key Youth-Associated Proteins. | Aging Cell | 2026 | 41655127 | PubTator, text mining | PubMed |
| Complementary roles of HMGB1 and PRDX4 in the pathophysiology of steroid-associated osteonecrosis of the femoral head: a histopathological and immunohistochemistry study. | Virchows Arch | 2026 | 41639395 | PubTator, text mining | PubMed |
| Peroxiredoxin 2 contributes to the malignant phenotype of glioblastoma cells. | Biochem Biophys Res Commun | 2026 | 41619511 | PubTator, text mining | PubMed |
| Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models. | Brain Behav | 2026 | 41603055 | PubTator, text mining | PubMed |
| Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer. | NPJ Precis Oncol | 2026 | 41571856 | PubTator, text mining | PubMed |
| Tear proteomics reveals biomarkers for visual field progression in normal-tension glaucoma. | Int J Ophthalmol | 2026 | 41524014 | PubTator, text mining | PubMed |
| Integrated transcriptomic analysis and experimental validation identify ACADL as a mitochondrial tumor suppressor via the FOXO3a/PUMA axis in lung adenocarcinoma. | Eur J Med Res | 2026 | 41491963 | PubTator, text mining | PubMed |
| From Drops to Decisions: AI/ML-Driven Biofluidics for Clinical Diagnostics and Healthcare Intelligence. | Anal Chem | 2026 | 41433142 | PubTator, text mining | PubMed |
| Salivary proteomics profiling in cutaneous lupus erythematosus. | Lupus | 2026 | 41408937 | PubTator, text mining | PubMed |
| Potential role of exosomes derived from the tumor microenvironment in tumor progression and treatment. | Front Oncol | 2025 | 41726368 | PubTator, text mining | PubMed |
| Commentary: Low expression of SOD and PRX4 as indicators of poor prognosis and systemic inflammation in colorectal cancer. | Front Oncol | 2025 | 41479776 | PubTator, text mining | PubMed |
| Integrative MultiOmics and Machine Learning Reveal Peroxiredoxin 4 as a Critical Hub Governing Mitochondrial Dysfunction and B Cell Differentiation in Periodontitis. | Clin Cosmet Investig Dent | 2025 | 41467033 | PubTator, text mining | PubMed |
| Bioinformatic Approach to Identify Positive Prognostic TGFB2-Dependent and Negative Prognostic TGFB2-Independent Biomarkers for Breast Cancers. | Int J Mol Sci | 2025 | 41373732 | PubTator, text mining | PubMed |
| Low expression of SOD and PRX4 as indicators of poor prognosis and systemic inflammation in colorectal cancer. | Front Oncol | 2025 | 41262897 | PubTator, text mining | PubMed |
| Identification of Oxidative Stress-Related Shared Biomarkers in Vitiligo and Periodontitis: A Bioinformatics and Machine Learning Study. | Clin Cosmet Investig Dermatol | 2025 | 41158793 | PubTator, text mining | PubMed |
| Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers. | J Crohns Colitis | 2025 | 41063386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10549/papers?page=2